Euroespes (XMAD:EEP) Interest Coverage : 0 (At Loss) (As of Dec. 2022)

View and export this data going back to 2011. Start your Free Trial

What is Euroespes Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Euroespes's Operating Income for the six months ended in Dec. 2022 was €-0.85 Mil. Euroespes's Interest Expense for the six months ended in Dec. 2022 was €-0.06 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Euroespes's Interest Coverage or its related term are showing as below:

XMAD:EEP's Interest Coverage is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 12.84
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Euroespes Interest Coverage Historical Data

The historical data trend for Euroespes's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Euroespes Interest Coverage Chart

Euroespes Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Coverage

Get a 7-Day Free Trial

Euroespes Semi-Annual Data
	Dec12	Jun13	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Interest Coverage	Get a 7-Day Free Trial															-	-	1.06	-	-

Competitive Comparison of Euroespes's Interest Coverage

For the Diagnostics & Research subindustry, Euroespes's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Euroespes's Interest Coverage Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Euroespes's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Euroespes's Interest Coverage falls into.

Euroespes Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Euroespes's Interest Coverage for the fiscal year that ended in Dec. 2022 is calculated as

Here, for the fiscal year that ended in Dec. 2022, Euroespes's Interest Expense was €-0.10 Mil. Its Operating Income was €-1.11 Mil. And its Long-Term Debt & Capital Lease Obligation was €2.60 Mil.

Euroespes did not have earnings to cover the interest expense.

Euroespes's Interest Coverage for the quarter that ended in Dec. 2022 is calculated as

Here, for the six months ended in Dec. 2022, Euroespes's Interest Expense was €-0.06 Mil. Its Operating Income was €-0.85 Mil. And its Long-Term Debt & Capital Lease Obligation was €2.60 Mil.

Euroespes did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's Financial Strength is.

Euroespes (XMAD:EEP) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Euroespes Interest Coverage Related Terms

Thank you for viewing the detailed overview of Euroespes's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Euroespes (XMAD:EEP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Euroespes SA (XMAD:EEP) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

N/A

Address

Santa Marta de Babio, Bergondo, La Coruna, ESP, 15165

Website

http://www.euroespes.com

Euroespes SA is a biomedical research center offering medical, research, medical informatics and bioinformatics services. It offers medicine and personalized treatment for central nervous system disorders and researches genomic medicine. Other services offered by the company include genomics, digital diagnosis, diagnostic imaging, neuro-psychology, neuro-ophthalmology, nursing, epigenetics, clinical analysis and otorhinolaryngology.